Skip to content

Schistosomiasis and Other Trematode Infections

Chapter 241 | Part 5: Infectious Diseases

KEY CLINICAL POINTS

  • Schistosomiasis is caused by six Schistosoma species (S. mansoni, S. japonicum, S. intercalatum, S. haematobium, S. mekongi, S. guineensis) with distinct geographic distributions and transmission routes.
  • Diagnosis relies on detection of schistosome eggs in stool/urine, serology, imaging, and PCR; treatment is praziquantel (40-60 mg/kg PO), with no effective drugs for dracunculiasis.
  • Climate change and environmental factors significantly impact snail intermediate host distribution, altering schistosomiasis transmission dynamics globally.

1. DEFINITION & OVERVIEW

Trematodes (flukes) are helminths causing human infections through complex life cycles involving snail intermediate hosts. Key infections include schistosomiasis (blood flukes) and food-borne trematode infections (liver, intestinal, lung flukes).

Table 241-1 Major Human Trematode Infections

TREMATODE TRANSMISSION ROUTE GEOGRAPHIC DISTRIBUTION
Schistosoma mansoni Skin penetration by cercariae from Biomphalaria snails Africa, Brazil, Venezuela, Surinam, Caribbean (low risk)
Schistosoma japonicum Skin penetration by cercariae from Oncomelania snails China, Indonesia, Philippines
Schistosoma guineensis/S. intercalatum Skin penetration by cercariae from Bulinus snails Central African rainforests
Schistosoma mekongi Skin penetration by cercariae from Neotricula aperta snails Cambodia, Lao PDR
Clonorchis sinensis Ingestion of metacercariae in freshwater fish Asia (Korea, China, Vietnam)
Opisthorchis viverrini/felineus Ingestion of metacercariae in freshwater fish Southeast Asia, Europe
Fasciola hepatica/gigantica Ingestion of metacercariae on aquatic plants/water Global (F. hepatica), Africa/Asia (F. gigantica)
Fasciolopsis buski Ingestion of metacercariae on aquatic plants Bangladesh, China, India, Indonesia
Paragonimus westermani/kellicotti Ingestion of metacercariae in crayfish/crabs Tropical/subtropical Asia, Americas, sub-Saharan Africa

1.1 Schistosomiasis

Caused by Schistosoma species, characterized by adult worms in mesenteric/pelvic veins, egg deposition in tissues, and immune-mediated granulomas. S. haematobium causes urogenital disease; others cause intestinal disease.

1.2 Food-Borne Trematode Infections

Infections from liver (Clonorchis, Opisthorchis, Fasciola), intestinal (Fasciolopsis, Echinostoma), and lung flukes (Paragonimus). Transmission via ingestion of metacercariae in raw fish, plants, or crustaceans.

2. EPIDEMIOLOGY

Schistosomiasis affects 251.4 million people globally (78% in sub-Saharan Africa), with 75.3 million treated in 2021. Dracunculiasis (Guinea worm) has 13 human cases in 2022, with snail reservoirs in dogs/cats complicating eradication. Climate change impacts snail distribution and transmission.

2.1 Schistosomiasis

Children acquire infection at 3-4 years via contaminated water; prevalence peaks at 10-15 years. Adult worms persist 3-5 years, with 30-year lifespan in severe cases. 70% of cases in sub-Saharan Africa.

2.2 Dracunculiasis

13 human cases in 2022 (Chad, South Sudan). Transmission via Cyclops intermediate hosts; no effective drugs. Prevention relies on safe water access.

3. ETIOLOGY & PATHOPHYSIOLOGY

Schistosomes have complex life cycles with snail intermediate hosts. Eggs trigger granulomatous inflammation and fibrosis. Immune evasion via surface protein binding and proteolytic enzymes. S. haematobium is IARC Group 1 carcinogen (bladder cancer).

3.1 Life Cycle

Snail intermediate host → cercariae → skin penetration → adult worms in portal/venous system → egg deposition in tissues. Eggs induce Th2 immune response with eosinophilia.

3.2 Pathogenesis

Egg-induced granulomas cause periportal fibrosis, portal hypertension, and organ-specific damage. S. haematobium eggs cause bladder squamous cell carcinoma.

4. CLINICAL FEATURES

Three stages: acute (Katayama fever), active (organ-specific symptoms), chronic (fibrosis, portal hypertension). Urogenital schistosomiasis causes bladder inflammation, hematuria, and carcinoma. Pulmonary schistosomiasis from portacaval shunting.

4.1 Schistosomiasis Stages

Acute: fever, eosinophilia, pulmonary infiltrates. Active: intestinal pain, hepatosplenomegaly. Chronic: portal hypertension, fibrosis, cholangiocarcinoma.

4,2 Food-Borne Trematode Infections

Liver flukes: biliary colic, cholangitis, pancreatitis. Intestinal flukes: malabsorption, abdominal pain. Lung flukes: pulmonary cysts, CNS complications.

5. DIFFERENTIAL DIAGNOSIS

Acute fevers: malaria, salmonellosis, tropical eosinophilia. Urogenital symptoms: bladder cancer, tuberculosis. Pulmonary symptoms: tuberculosis, fungal infections. Eosinophilia: helminth infections, allergic reactions.

6. INVESTIGATIONS & DIAGNOSIS

Diagnosis via stool/urine microscopy for eggs, serology (FAST-ELISA, immunoblot), PCR, and imaging (ultrasound, CT). Cercarial dermatitis presents as maculopapular rash. Neuroschistosomiasis requires CSF analysis.

6.1 Diagnostic Methods

Egg detection in stool (50 mg) or urine (10 mL). Formol-ether concentration for low egg counts. PCR for sensitive detection. Serology for travelers.

6.2 Imaging

Ultrasound for hepatosplenomegaly, portal hypertension. CT/MRI for biliary duct thickening, pulmonary granulomas. Endoscopy for urogenital tract evaluation.

7. MANAGEMENT & TREATMENT

Praziquantel (40-60 mg/kg PO) is first-line for schistosomiasis. No drugs for dracunculiasis; excision required. Food-borne flukes treated with praziquantel or triclabendazole. Prevention via water sanitation and snail control.

7.1 Schistosomiasis

Praziquantel 40-60 mg/kg PO for S. mansoni/japonicum. Repeat dosing if symptoms persist. Glucocorticoids for acute Katayama fever.

7.2 Food-Borne Trematodes

Praziquantel 25-75 mg/kg for liver/intestinal flukes. Triclabendazole for Fasciola (10 mg/kg x2). Avoid raw freshwater fish in endemic areas.

8. PROGNOSIS & COMPLICATIONS

Chronic schistosomiasis leads to portal hypertension, fibrosis, and cholangiocarcinoma. Dracunculiasis causes severe ulcers and secondary infections. Climate change threatens future transmission patterns.

8.1 Long-Term Outcomes

Hepatosplenomegaly resolves with treatment, but fibrosis persists. S. haematobium increases bladder cancer risk. Severe cases may progress to uremia or liver failure.

8.2 Complications

Portal hypertension, esophageal varices, obstructive uropathy, and ectopic infections. Neuroschistosomiasis may cause transverse myelitis or encephalopathy.

9. SPECIAL CONSIDERATIONS

Schistosomiasis is a poverty-related disease; prevention requires water sanitation. Travelers should avoid freshwater contact in endemic areas. HIV co-infection may exacerbate genital schistosomiasis.

10. KEY POINTS & CLINICAL PEARLS

  1. Praziquantel is the only effective drug for schistosomiasis; no treatment exists for dracunculiasis. 2. Snail control and water sanitation are critical for prevention. 3. Egg detection in stool/urine is the gold standard for diagnosis. 4. Climate change impacts snail distribution and transmission dynamics.